Exterran corporation (EXTN)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Cash flows from operating activities:
Net loss

-18,304

-79,837

-9,841

-7,305

-5,394

14,073

5,369

75

5,337

6,662

3,353

3,544

20,321

-26,774

-12,660

-95,546

-92,957

-4,083

8,677

-14,423

36,477

Adjustments to reconcile net loss to cash provided by operating activities:
Depreciation and amortization

32,610

45,888

42,133

36,319

38,217

31,601

31,108

30,184

31,029

29,714

27,010

26,348

24,752

26,353

28,183

27,417

50,933

36,167

36,083

36,053

38,015

Impairments

-

-

-

-

-

0

2,054

0

1,804

5,700

0

0

0

8,486

5,358

0

651

6,524

3,775

5,910

4,579

Amortization of deferred financing costs

628

628

628

628

628

1,333

672

672

670

670

669

2,244

1,131

1,131

1,132

1,241

1,080

702

0

0

0

(Income) loss from discontinued operations, net of tax

-154

412

-1,546

7,457

163

19,346

2,173

1,544

1,399

4,579

2,139

374

32,644

-22,732

19,652

11,036

-64,127

-31,691

18,275

207

17,932

Provision for doubtful accounts

2,742

32

0

0

0

-572

52

391

215

-520

430

467

486

871

707

631

763

1,714

586

850

176

Gain on sale of property, plant and equipment

161

1,826

229

132

1,000

284

-3

121

227

1,122

150

1,211

34

632

53

2,200

101

645

132

903

125

Income (Loss) from Equity Method Investments

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

5,229

5,174

0

5,084

5,062

5,006

Gain on remeasurement of intercompany balances

1,121

147

-884

591

446

-955

-164

-3,451

-630

-1,973

2,447

-1,436

1,462

-622

2,376

2,936

4,610

5,423

-27,551

-491

-7,508

Loss on foreign currency derivatives

0

0

0

-129

-665

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Loss on sale of businesses

-

-

-

-

-

-

-

-

-

0

0

0

-111

0

0

0

0

-

-

-

-

Stock-based compensation expense

285

2,393

2,874

3,487

3,996

3,736

3,773

3,454

3,604

3,099

3,104

3,258

5,303

805

2,905

2,863

4,393

2,826

1,602

1,741

2,015

Deferred income tax expense (benefit)

1,361

-4,195

-1,531

-3,301

-980

6,264

-1,361

-1,660

-1,706

-466

4,354

-7,033

-48

-2,018

290

81,745

-8,927

-7,178

-18,484

-4,778

4,602

Changes in assets and liabilities:
Accounts receivable and notes

-1,801

-30,148

-36,328

-938

16,684

5,457

-18,001

24,690

-20,815

10,149

14,269

-2,030

42,923

1,475

-2,886

-44,463

-80,402

6,643

14,581

-23,480

-32,172

Inventory

-4,632

-15,717

-5,174

9,833

19,427

8,609

-19,059

35,834

34,292

-10,752

-3,841

-12,141

6,140

-4,875

-8,119

-22,953

-13,789

-51,399

-26,632

-28,782

26,397

Costs and estimated earnings versus billings on uncompleted contracts

-

-

-

-

-

-

-

-

-

13,538

-22,646

20,290

-52,131

-8,059

-12,981

9,232

-12,829

1,807

-318

37,230

-14,391

Contract assets

-3,301

20,938

-5,241

-26,804

-17,245

18,308

-5,319

-9,815

31,397

0

0

0

0

-

-

-

-

-

-

-

-

Other current assets

382

-3,775

-8,816

-7,193

-528

28

4,252

-1,386

-7,939

-2,402

-1,958

7,821

-1,920

13,544

4,226

-6,422

-4,274

-4,078

465

-8,571

12,346

Accounts payable and other liabilities

-50,836

22,176

-49,460

-21,567

7,759

-15,315

-10,471

33,118

6,469

21,513

17,203

16,401

6,912

27,811

10,663

-29,543

-6,853

-12,904

-9,168

-13,228

-47,295

Deferred revenue

-

-

-

-

-

-

-

-

-

-16,493

8,120

-5,971

633

-669

1,502

17,391

6,190

6,105

-5,602

640

-3,571

Contract liabilities

27,203

-32,335

-9,051

9,072

24,051

74,871

-8,191

2,683

-6,429

0

0

0

0

-

-

-

-

-

-

-

-

Other

-5,536

-8,639

-687

5,502

-30

452

-1,527

-1,420

-564

6,416

8,053

-1,080

1,094

7,334

-2,939

-3,641

103

6,384

-16,948

12,168

3,202

Net cash provided by continuing operations

9,449

55,203

37,169

34,801

49,025

64,503

60,653

24,514

3,626

29,186

65,630

26,249

29,355

49,453

38,739

53,591

120,706

96,139

50,381

18,519

24,061

Net cash provided by (used in) discontinued operations

-1,177

561

-1,135

3,086

16

2,860

263

3,730

-2,849

143

-4,435

-3,013

5,511

3,300

879

-5,350

2,187

-64,354

1,876

4,803

271

Net cash provided by operating activities

8,272

55,764

36,034

37,887

49,041

67,363

60,916

28,244

777

29,329

61,195

23,236

34,866

52,753

39,618

48,241

122,893

31,785

52,257

23,322

24,332

Cash flows from investing activities:
Capital expenditures

17,025

21,156

46,002

49,762

76,354

62,882

57,992

45,015

49,219

52,551

34,906

23,626

20,590

25,981

16,902

16,336

14,451

33,247

40,638

40,936

40,523

Proceeds from sale of property, plant and equipment

164

15,380

133

137

4,012

100

58

112

2,260

2,311

128

3,843

2,584

1,842

73

814

85

1,334

189

1,486

3,600

Proceeds from Divestiture of Businesses

-

-

-

-

-

-

-

-

-

0

0

0

894

0

0

0

0

-

-

-

-

Proceeds from Sale of Equity Method Investments

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

5,229

5,174

0

5,117

5,062

5,006

Settlement of foreign currency derivatives

0

0

0

587

207

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in continuing operations

-

-

-

-

-

-62,782

-57,934

-39,903

-46,959

-50,240

-34,778

-19,783

-17,112

-24,860

-16,764

-10,346

-9,192

-31,912

-35,366

-29,031

-31,917

Cash Provided by (Used in) Investing Activities, Discontinued Operations

-

-

-

-

-

16,943

0

0

66

221

190

14

19,150

-655

22,097

16,464

-1,827

14,839

15,925

-1,156

16,504

Net cash used in investing activities

-16,861

-5,776

-45,869

-50,212

-72,549

-45,839

-57,934

-39,903

-46,893

-50,019

-34,588

-19,769

2,038

-25,515

5,333

6,118

-11,019

-17,073

-19,441

-30,187

-15,413

Cash flows from financing activities:
Proceeds from borrowings of debt

112,000

112,500

144,000

207,000

179,000

170,014

160,000

188,500

66,500

13,088

0

427,500

60,500

77,000

69,500

126,758

157,500

673,500

0

0

0

Repayments of debt

100,613

164,613

108,113

182,112

149,113

185,126

142,613

174,195

48,563

12,563

63

370,814

93,063

101,313

96,563

159,822

252,563

143,500

0

0

0

Payment for Spin-off Transaction

-

-

-

-

-

-

-

-

-

0

0

25,000

19,720

0

19,514

24,509

5,153

532,578

0

0

0

Payments for debt issuance costs

-

-

-

-

-

4,709

45

0

47

0

305

7,606

0

-

-

-

-

-

-

-

-

Net contributions from parent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,401

Proceeds from stock options exercised

-

-

-

-

-

0

-15

135

428

0

0

0

684

92

0

0

694

0

0

0

0

Purchases of treasury stock (Note 10)

835

3,411

20,285

14,610

6,701

843

299

41

3,440

1,473

195

100

3,024

647

17

13

1,414

54

0

0

0

Net cash provided by financing activities

10,552

-55,524

15,602

10,698

23,186

-39,408

17,028

14,399

14,878

-948

-563

23,980

-54,623

-24,868

-46,594

-58,365

-100,936

-14,886

-23,726

-20,984

3,401

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-513

240

-966

70

-402

-150

-1,236

-1,884

-571

-419

-331

-97

55

436

276

-1,559

-985

-2,740

-193

-552

-231

Net increase (decrease) in cash, cash equivalents and restricted cash

1,450

-5,296

4,801

-1,557

-724

-18,034

18,774

856

-31,809

-22,057

25,713

27,350

-17,664

2,806

-1,367

-5,565

9,953

-2,914

8,897

-28,401

12,089

Supplemental disclosure of non-cash transactions:
Accrued capital expenditures

6,959

-

-

-

18,964

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-